Target intelligence / Profile preview

Caspase 3 pseudogene 1 (CASP3P1)

Target
CASP3P1
Molecular classification
Other (Pseudogene)
01

Overview

Caspase 3 pseudogene 1 (CASP3P1) is classified as a pseudogene, an inactive genomic DNA sequence similar to the functional caspase 3 (CASP3) gene but incapable of producing a functional protein product[4]. In contrast to the true caspase 3 enzyme—which is a critical executioner protease in the apoptotic pathway and a target of drug discovery—CASP3P1 has no known protein-coding function or therapeutically relevant activity. There is no evidence that CASP3P1 is involved in disease, serves as a biomarker, or interacts with any drugs. Its biological relevance, if any, would be indirect, such as effects via non-coding RNA regulation, for which there is currently no published evidence specific to CASP3P1[4]. Note on correctness: The query refers to a pseudogene, not the functional caspase 3 enzyme (CASP3). Pseudogenes are not considered therapeutic targets unless there is exceptional evidence for a functional role—which is lacking for CASP3P1[4]. References to further distinguish from the functional target: - Functional caspase-3 (CASP3) is an executioner caspase essential to apoptosis[1][2]. - CASP3 is a drug target; CASP3P1, by contrast, has no such role[4].

Other names
Caspase 3, apoptosis-related cysteine peptidase pseudogene 1CASP3P1
02

Biological functions

Other (Pseudogenes generally do not have direct biological functions; some pseudogenes may act as competing endogenous RNAs or have regulatory effects in rare cases, but no such function is established for CASP3P1[4])

Beyond the preview

Go deeper on Caspase 3 pseudogene 1 (CASP3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caspase 3 pseudogene 1 (CASP3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call